Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02528877
Title Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

myelofibrosis

acute myeloid leukemia

Therapies

Fludarabine + Melphalan

Ruxolitinib + Sirolimus + Tacrolimus

Age Groups: adult
Covered Countries USA


No variant requirements are available.